Wilde, Michelle I.; Spencer, Caroline M. - In: Disease Management and Health Outcomes 3 (1998) 6, pp. 293-311
3-hydroxy-3-methylglutaryl-coenzyme-A (HMG-CoA) reductase inhibitors (`statins'), fibric acid derivatives, bile acid … similar tolerability profile to other HMG-CoA reductase inhibitors; however, longer term tolerability data are required …-effective than other HMG-CoA reductase inhibitors in terms of cost per unit of cholesterol lowering achieved; confirmatory data are …